Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis.
about
Metabolic syndrome, inflammation and lower urinary tract symptoms: possible translational linksTadalafil for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a review of clinical data in Asian men and an update on the mechanism of actionMetabolic profiling of cholesterol and sex steroid hormones to monitor urological diseasesInsulin Resistance Is Associated with Prevalence of Physician-Diagnosed Urinary Incontinence in Postmenopausal Non-Diabetic Adult Women: Data from the Fourth Korea National Health and Nutrition Examination Survey.The study about physical activity for subjects with prevention of benign prostate hyperplasia.Can metabolic disorders in aging men contribute to prostatic hyperplasia eligible for transurethral resection of the prostate (TURP)?Effect of Silodosin, an Alpha1A-Adrenoceptor Antagonist, on Ventral Prostatic Hyperplasia in the Spontaneously Hypertensive Rat.Correlations of Metabolic Components with Prostate Volume in Middle-Aged Men Receiving Health Check-UpAssociation between benign prostatic hyperplasia, body mass index, and metabolic syndrome in Chinese men.Metabolic syndrome and benign prostatic hyperplasia: association or coincidence?Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study.The Association Between Metabolic Syndrome and Characteristics of Benign Prostatic Hyperplasia: A Systematic Review and Meta-Analysis.Smoking habits and benign prostatic hyperplasia: A systematic review and meta-analysis of observational studiesAssociations between metabolic syndrome and clinical benign prostatic hyperplasia in a northern urban Han Chinese population: A prospective cohort study.Obesity as a Risk Factor for Prostatic Enlargement: A Retrospective Cohort Study in Korea.Testosterone Replacement Therapy on the Natural History of Prostate Disease.Connections between lower urinary tract symptoms related to benign prostatic enlargement and metabolic syndrome with its components: a systematic review and meta-analysis.Emerging links between non-neurogenic lower urinary tract symptoms secondary to benign prostatic obstruction, metabolic syndrome and its components: A systematic review.Relationship between lower urinary tract symptoms and cardiovascular risk scores including Framingham risk score and ACC/AHA risk score.Lower urinary tract symptoms, benign prostatic hyperplasia and metabolic syndrome.Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis.The Impact of Central Obesity on Storage Luts and Urinary Incontinence After Prostatic Surgery.Association of Obesity-Related Hemodilution of Prostate-Specific Antigen, Dihydrotestosterone, and Testosterone.Meta-analysis of metabolic syndrome and prostate cancer.Testosterone Replacement Therapy: Long-Term Safety and Efficacy.Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross-sectional, UK epidemiological study.Looking to the metabolic landscapes for prostate health monitoringBenign prostatic enlargement is not associated with diabetes: a population-based study.Central obesity is predictive of persistent storage lower urinary tract symptoms (LUTS) after surgery for benign prostatic enlargement: results of a multicentre prospective study.Protective effect of tadalafil on the functional and structural changes of the rat ventral prostate caused by chronic pelvic ischemia.The Effect of Different Metabolic Syndrome: Definitions on the Relationship Between Metabolic Syndrome and LUTS in Men With Benign Prostatic Enlargement.Letter to the Editor regarding the article "Association of elevated interleukin-17 and angiopoietin-2 with prostate size in benign prostatic hyperplasia".Exercise, diet and weight loss before therapy for lower urinary tract symptoms/benign prostatic hyperplasia?Emerging drugs for the treatment of benign prostatic hyperplasia.Clinical guidelines for male lower urinary tract symptoms and benign prostatic hyperplasia.Comparison of the effectiveness of IPSS and VPSS without any help in LUTS patients: a prospective study.Association between metabolic syndrome and intravesical prostatic protrusion in patients with benign prostatic enlargement and lower urinary tract symptoms (MIPS Study).The relationship between acquired premature ejaculation and metabolic syndrome: a prospective, comparative study.Heme oxygenase levels and metaflammation in benign prostatic hyperplasia patients.Autoantibodies Directed Against the Endothelin A Receptor in Patients With Benign Prostatic Hyperplasia.
P2860
Q26782663-ADF780A5-596A-4D2B-9F87-8A2E7A1ECBE6Q26783529-D481ACC1-E64B-4F96-BCB6-50667CC12CDCQ28079470-3A263585-4135-43CA-B053-4798D2334A03Q31015734-6DE97414-3D5A-43AB-868D-A7C611A4EC6BQ34267524-8B7FEB1B-2250-4C58-A48B-0834A11BED49Q35228167-73E5BEFE-45F4-44E5-A7E7-27FFFE498C3AQ35755940-FB9840AF-6D47-4D08-AFB3-62D0213EED38Q35885619-39FCA8EF-9F2E-40CF-A233-3DC6B59A5B5AQ36080363-266A821F-6344-4468-9665-4EA111B3E62AQ36224259-2633738B-3902-4D41-AACD-90F4B4D2A0B4Q36334566-867FB9F9-13EB-4626-8FF3-DB8A453F55CFQ36993287-F2E9962D-5705-4F87-AAA6-0F65A4C84393Q37176065-A14EE4F5-0880-4CA3-90D0-0232BF38C1A2Q37274150-11F76148-A80A-437C-91B1-6ECE70C5B64CQ37553992-ACCE15DA-ECD7-4D43-BE69-0AA8D85298EBQ38528388-A9BE77C7-6CF0-4E0D-8A54-01B8A6214656Q38546659-E1B9CFD4-144A-4113-90F9-35B0AD6BF3F5Q38550856-A496B908-B6A7-4E1A-B8E1-19FE0ABAB58DQ38671544-E1285231-24C7-4183-925F-91E3FDEE6DF3Q38692706-8C82C806-A6F7-4FFE-A6E6-A4581904DE02Q38814349-B1B7CB52-C3AA-44D2-9137-A3BE08038A76Q38901781-0E78FF7D-F831-4BF4-9DCF-9420D6858788Q39090001-EFCC1600-CB9E-4C64-8FEF-F03E8FF8E584Q39145052-1CB41BCF-8215-4C4B-BEBE-848D7278EC5AQ39302080-19DC11EA-6A20-4283-991C-7EFA390167C7Q41337202-D8B42FEA-9D66-4036-9151-3AB4C41A22DDQ41345751-5448E3BE-7E8A-46BC-8188-6D1ED3125B81Q41542467-C00C926E-49AC-4647-B56F-B2D520B67004Q41568393-E2794D8C-B1C8-4479-BBA1-9B803285592CQ42200788-EDFABEBC-6428-41F2-93B5-C097D866F318Q47126131-8E50A4B1-D7DD-4FC8-A3A4-ADCBA6CE0161Q47191772-D16EAB40-A702-4703-9085-C8BCC7F9DC1EQ47373281-4DD6E48E-0CED-4F32-BA4A-A3CB0A267912Q47553287-C60644C0-7160-4E2B-A641-7E379B2B2F75Q47704193-BAD82177-E6C6-4048-A341-A907919F1A38Q48538834-18511A70-3718-465D-B429-4B2D42176D6BQ48595337-73848CA0-C7E7-4C08-A4DD-7453E7F41C11Q48699591-A5DCD7D4-A785-46D0-9815-D675B30196B0Q48909051-41F22F66-1B8B-4F2E-85ED-47DBDC8221CAQ48924237-2D7F92E4-54B7-4440-9D99-26EC717BBFC6
P2860
Metabolic syndrome and benign prostatic enlargement: a systematic review and meta-analysis.
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Metabolic syndrome and benign ...... atic review and meta-analysis.
@ast
Metabolic syndrome and benign ...... atic review and meta-analysis.
@en
Metabolic syndrome and benign ...... atic review and meta-analysis.
@nl
type
label
Metabolic syndrome and benign ...... atic review and meta-analysis.
@ast
Metabolic syndrome and benign ...... atic review and meta-analysis.
@en
Metabolic syndrome and benign ...... atic review and meta-analysis.
@nl
prefLabel
Metabolic syndrome and benign ...... atic review and meta-analysis.
@ast
Metabolic syndrome and benign ...... atic review and meta-analysis.
@en
Metabolic syndrome and benign ...... atic review and meta-analysis.
@nl
P2093
P2860
P50
P356
P1433
P1476
Metabolic syndrome and benign ...... atic review and meta-analysis.
@en
P2093
Andrea Tubaro
Linda Vignozzi
Marco Carini
Matteo Salvi
Matthias Oelke
Mauro Gacci
Sergio Serni
P2860
P356
10.1111/BJU.12728
P577
2014-08-16T00:00:00Z